Genetics

#AI / data analytics / healthtech / informatics #Genetics #Research

New report helps provide accurate identification of variants in genes 

Researchers from National Institute of Standards and Technology (NIST), Baylor College of Medicine and DNAnexus, together with other members of the Genome in a Bottle (GIAB) consortium, have announced the publication of a comprehensive benchmark dataset comprising 273 challenging medically-relevant autosomal genes that are associated with the development of… Read More

#News

#AstraZeneca #Biobanking #Genetics #Genomics

Rare variant contribution to human disease  

Listen to this article on the DDW Podcast: Slavé Petrovski and Andrew Harper, Centre for Genomics Research, AstraZeneca, outline the implications and insight offered by the recent publication of an AstraZeneca-authored paper “Rare variant contribution to human disease in 281,104 UK Biobank exomes”.  In August 2021, Nature published the largest and most comprehensive evaluation of the… Read More

#Exclusive Content #News #Opinion #Trends & Analysis

#Comment #Covid-19 #Genetics #Genomics #Public health #Research

Genomics boosts understanding of Covid-19 severity and susceptibility

Listen to this article on the DDW Podcast: The Covid-19 Host Genetics Initiative carried out one of the largest genome-wide association studies ever. It involved meta-analysis of nearly 50,000 Covid-19 patients and two million uninfected controls. Dr Hamdi Mbarek, Lead Analyst of the Qatari dataset explains how the initiative improved knowledge… Read More

#Covid-19 #Editor's Choice #Exclusive Content #News #Opinion #Trends & Analysis

#Cancer research #Genetics #Tumours

Scientists find that the way tumours grow impacts their genetics

Researchers at the Francis Crick Institute, UCL, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London have developed a computer model to analyse how the way in which tumours grow affects their genetic makeup. Using this new model, they have identified links between tumour growth… Read More

#News

#Alzheimer's #Drug discovery #Genetics #Life sciences #Neuroscience #Therapeutics

Is new thinking the key to unlocking Alzheimer’s treatment?

Professor Paul Whiting, Chief Scientific Officer of The Alzheimer’s Research UK UCL Drug Discovery Institute (ARUK UCL DDI), and Stephane Martinez, product manager and neuroscience expert in PerkinElmer’s Life Sciences segment, share expert insights on Alzheimer’s Disease research today and where discovery and therapeutic approaches might be headed next. Read More

#Editor's Choice #News #Opinion

#Cell painting #Drug discovery #Genetics

PerkinElmer’s support creates world’s largest public cell painting dataset

PerkinElmer is providing its PhenoVue Cell Painting Kits to the Joint Undertaking in Morphological Profiling-Cell Painting (JUMP-CP) consortium. The consortium, spearheaded by the Broad Institute of MIT and Harvard and including leading pharmaceutical companies and non-profit research organisations, is focused on creating and sharing the world’s largest, public cell imaging… Read More

#News

#Genetics #Neuroscience #Research study #Schizophrenia

Flies with schizophrenia genes respond well to anti-psychotics

Scientists have successfully treated flies displaying behavioural problems linked to newly discovered schizophrenia-associated genes in humans, using common anti-psychotics. Schizophrenia is a severe long-term mental health condition that is historically poorly understood and treated. It is relatively common, affecting 1-2% of the population, and is known to be up to… Read More

#News

#Corning Life Sciences #Drug delivery #Drug development #Drug discovery #Gene therapy #Genetics #Genetics / genomes #Life sciences #Research

Process Development in Gene Therapy: Four Things to Know

By John Yoshi Shyu, Ph.D. Corning Life Sciences. Gene therapy – the addition, deletion, or modification of genes in living organisms – has been around, at least in concept, since the 1980s. Gene modification or editing incorporates two main strategies: insertion of novel genetic constructs into existing genes, and gene… Read More

#Exclusive Content #News

#Biotechnology #Cell and gene therapy #Cell therapy #Genetics

Partnership to advance diversified gene therapy pipeline

Gene therapy company AavantiBio and Catalent, technologies, development, and manufacturing solutions service, have partnered to support the development and manufacturing of AavantiBio’s gene therapies, including Friedreich’s Ataxia (FA). Catalent will provide process development and CGMP manufacturing of AavantiBio’s adeno-associated viral (AAV) vector-based therapeutic candidate for use in clinical trials in the… Read More

#News

#Biotherapeutics #Cancer research #DNA #Genetics #Radiology #Research

Researchers identify new role for protein in treatment of cancer

In a study by Yale Cancer Centre, researchers report on the discovery of a new role for STimulator of INterferon Genes, or STING. STING has traditionally been implicated in the immune response to DNA damage, however, in this study, the focus is on STING’s role in the tumour DNA damage… Read More

#Cancer Research #News

#Cell and gene therapy #Genetics #Genetics / genomics #Research

Genetic variants that impact immune cell functioning identified

New research has found that certain genetic variants that cause modified protein binding in immune cells are also seen in those at high risk of some autoimmune diseases. Scientists from the Wellcome Sanger Institute, Josep Carreras Leukaemia Research Institute in Spain, and the MRC London Institute of Medical Sciences (LMS)… Read More

#News

#Cancer research #Cell and gene therapy #Cell sequencing #DNA #Genetics

Scientists discover ‘jumping’ genes can protect against blood cancers

New research has uncovered an unexpected role for so-called “jumping” genes that are a source of genetic mutations responsible for many human diseases. In the new study from Children’s Medical Centre Research Institute at UT Southwestern (CRI), scientists discovered that these DNA sequences, also known as transposons, can protect against… Read More

#Cancer Research #News

#Cell sequencing #Database #Genetics #Software

New search engine for single cell atlases

Wellcome Sanger Institute researchers have developed new software to quickly query databases generated from single-cell sequencing. The open access scfind software can be used to identify which cell types are active in any combination of genes, and enables analysis of multiple datasets containing millions of cells by a wide range… Read More

#News

#Genetics #Zebrafish

Compound isolated from human sperm could treat genetic disorder

A newly discovered genetic condition caused by faulty protein synthesis which causes delayed development and learning difficulties could be treated by a compound originally isolated from human sperm, say scientists. The University of Manchester researchers, with collaborators from the UK, France and US, identified rare changes in a gene called… Read More

#Editor's Choice #News

#Genetics #Immune cells

New 3D maps reveal inner workings of immune cell gene expression

The COVID-19 pandemic has highlighted how our small genetic differences can have a tremendous effect on how our bodies respond to disease. “The difference is within us,” said Vivek Chandra, an instructor at La Jolla Institute for Immunology (LJI). “We can get infected by the same bacteria or viruses, but… Read More

#News